311 related articles for article (PubMed ID: 28168735)
1. Does imiquimod pretreatment optimize 308-nm excimer laser (UVB) therapy in psoriasis patients?
Tacastacas JD; Oyetakin-White P; Soler DC; Young A; Groft S; Honda K; Cooper KD; McCormick TS
Photodermatol Photoimmunol Photomed; 2017 Jul; 33(4):193-202. PubMed ID: 28168735
[TBL] [Abstract][Full Text] [Related]
2. Topical 8-methoxypsoralen enhances the therapeutic results of targeted narrowband ultraviolet B phototherapy for plaque-type psoriasis.
Asawanonda P; Amornpinyokeit N; Nimnuan C
J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):50-5. PubMed ID: 18181973
[TBL] [Abstract][Full Text] [Related]
3. NB-UVB irradiation downregulates keratin-17 expression in keratinocytes by inhibiting the ERK1/2 and STAT3 signaling pathways.
Zhuang Y; Han C; Li B; Jin L; Dang E; Fang H; Qiao H; Wang G
Arch Dermatol Res; 2018 Mar; 310(2):147-156. PubMed ID: 29349514
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the 308-nm excimer laser and a 308-nm excimer lamp with 311-nm narrowband ultraviolet B in the treatment of psoriasis.
Köllner K; Wimmershoff MB; Hintz C; Landthaler M; Hohenleutner U
Br J Dermatol; 2005 Apr; 152(4):750-4. PubMed ID: 15840108
[TBL] [Abstract][Full Text] [Related]
5. Targeted 307 nm UVB-phototherapy in psoriasis. A pilot study comparing a 307 nm excimer light with topical dithranol.
Wollina U; Koch A; Scheibe A; Seme B; Streit I; Schmidt WD
Skin Res Technol; 2012 May; 18(2):212-8. PubMed ID: 22092772
[TBL] [Abstract][Full Text] [Related]
6. Losartan ointment attenuates imiquimod-induced psoriasis-like inflammation.
Shokrian Zeini M; Haddadi NS; Shayan M; Shokrian Zeini M; Kazemi K; Solaimanian S; Abdollahifar MA; Hedayatyanfard K; Dehpour AR
Int Immunopharmacol; 2021 Nov; 100():108160. PubMed ID: 34583123
[TBL] [Abstract][Full Text] [Related]
7. Non-invasive evaluation of tacalcitol plus puva versus tacalcitol plus UVB-NB in the treatment of psoriasis: "right-left intra-individual pre/post comparison design".
Brazzelli V; Barbagallo T; Prestinari F; Rona C; De Silvestri A; Trevisan V; Borroni G
Int J Immunopathol Pharmacol; 2005; 18(4):755-60. PubMed ID: 16388725
[TBL] [Abstract][Full Text] [Related]
8. Azithromycin impairs TLR7 signaling in dendritic cells and improves the severity of imiquimod-induced psoriasis-like skin inflammation in mice.
Huang SW; Chen YJ; Wang ST; Ho LW; Kao JK; Narita M; Takahashi M; Wu CY; Cheng HY; Shieh JJ
J Dermatol Sci; 2016 Oct; 84(1):59-70. PubMed ID: 27449383
[TBL] [Abstract][Full Text] [Related]
9. Ultraviolet B 308-nm excimer laser treatment of psoriasis: a new phototherapeutic approach.
Gerber W; Arheilger B; Ha TA; Hermann J; Ockenfels HM
Br J Dermatol; 2003 Dec; 149(6):1250-8. PubMed ID: 14674904
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic modalities for localized psoriasis: 308-nm UVB excimer laser versus nontargeted phototherapy.
Mudigonda T; Dabade TS; West CE; Feldman SR
Cutis; 2012 Sep; 90(3):149-54. PubMed ID: 23094316
[TBL] [Abstract][Full Text] [Related]
11. Imiquimod attenuates the growth of UVB-induced SCC in mice through Th1/Th17 cells.
Yokogawa M; Takaishi M; Nakajima K; Kamijima R; Digiovanni J; Sano S
Mol Carcinog; 2013 Oct; 52(10):760-9. PubMed ID: 22431065
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of pathogenesis of imiquimod-induced skin inflammation in the mouse: a role for interferon-alpha in dendritic cell activation by imiquimod.
Ueyama A; Yamamoto M; Tsujii K; Furue Y; Imura C; Shichijo M; Yasui K
J Dermatol; 2014 Feb; 41(2):135-43. PubMed ID: 24387343
[TBL] [Abstract][Full Text] [Related]
13. Original Research: Different imiquimod creams resulting in differential effects for imiquimod-induced psoriatic mouse models.
Luo DQ; Wu HH; Zhao YK; Liu JH; Wang F
Exp Biol Med (Maywood); 2016 Oct; 241(16):1733-8. PubMed ID: 27190266
[TBL] [Abstract][Full Text] [Related]
14. Monochromatic excimer light (308 nm): an immunohistochemical study of cutaneous T cells and apoptosis-related molecules in psoriasis.
Bianchi B; Campolmi P; Mavilia L; Danesi A; Rossi R; Cappugi P
J Eur Acad Dermatol Venereol; 2003 Jul; 17(4):408-13. PubMed ID: 12834450
[TBL] [Abstract][Full Text] [Related]
15. Effective treatment of psoriasis with narrow-band UVB phototherapy is linked to suppression of the IFN and Th17 pathways.
Rácz E; Prens EP; Kurek D; Kant M; de Ridder D; Mourits S; Baerveldt EM; Ozgur Z; van IJcken WF; Laman JD; Staal FJ; van der Fits L
J Invest Dermatol; 2011 Jul; 131(7):1547-58. PubMed ID: 21412260
[TBL] [Abstract][Full Text] [Related]
16. Epidermal barrier and oxidative stress parameters improve during in 311 nm narrow band UVB phototherapy of plaque type psoriasis.
Darlenski R; Hristakieva E; Aydin U; Gancheva D; Gancheva T; Zheleva A; Gadjeva V; Fluhr JW
J Dermatol Sci; 2018 Jul; 91(1):28-34. PubMed ID: 29610017
[TBL] [Abstract][Full Text] [Related]
17. Langerin(neg) conventional dendritic cells produce IL-23 to drive psoriatic plaque formation in mice.
Wohn C; Ober-Blöbaum JL; Haak S; Pantelyushin S; Cheong C; Zahner SP; Onderwater S; Kant M; Weighardt H; Holzmann B; Reizis B; Becher B; Prens EP; Clausen BE
Proc Natl Acad Sci U S A; 2013 Jun; 110(26):10723-8. PubMed ID: 23754427
[TBL] [Abstract][Full Text] [Related]
18. 308-nm excimer laser in psoriasis vulgaris, scalp psoriasis, and palmoplantar psoriasis.
Gattu S; Rashid RM; Wu JJ
J Eur Acad Dermatol Venereol; 2009 Jan; 23(1):36-41. PubMed ID: 18717744
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of IL-17-committed T cells in a murine psoriasis model by a vitamin D analogue.
Kusuba N; Kitoh A; Dainichi T; Honda T; Otsuka A; Egawa G; Nakajima S; Miyachi Y; Kabashima K
J Allergy Clin Immunol; 2018 Mar; 141(3):972-981.e10. PubMed ID: 28870465
[TBL] [Abstract][Full Text] [Related]
20. IRF-2 haploinsufficiency causes enhanced imiquimod-induced psoriasis-like skin inflammation.
Kawaguchi M; Oka T; Sugaya M; Suga H; Kimura T; Morimura S; Fujita H; Sato S
J Dermatol Sci; 2018 Apr; 90(1):35-45. PubMed ID: 29305258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
